Hu et al., 2019 - Google Patents
808 nm near-infrared light-excited UCNPs@ mSiO2-Ce6-GPC3 nanocomposites for photodynamic therapy in liver cancerHu et al., 2019
View PDF- Document ID
- 1540584313769741113
- Author
- Hu J
- Shi J
- Gao Y
- Yang W
- Liu P
- Liu Q
- He F
- Wang C
- Li T
- Xie R
- Zhu J
- Yang P
- Publication year
- Publication venue
- International Journal of Nanomedicine
External Links
Snippet
Background It is important to explore effective treatment for liver cancer. Photodynamic therapy (PDT) is a novel technique to treat liver cancer, but its clinical application is obstructed by limited depth of visible light penetration into tissue. The near-infrared (NIR) …
- 238000002428 photodynamic therapy 0 title abstract description 38
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Su et al. | A supramolecular strategy to engineering a non-photobleaching and near-infrared absorbing nano-J-aggregate for efficient photothermal therapy | |
| Xu et al. | Combination of CuS and g-C3N4 QDs on upconversion nanoparticles for targeted photothermal and photodynamic cancer therapy | |
| Wu et al. | Porphyrin-implanted carbon nanodots for photoacoustic imaging and in vivo breast cancer ablation | |
| Hu et al. | 808 nm near-infrared light-excited UCNPs@ mSiO2-Ce6-GPC3 nanocomposites for photodynamic therapy in liver cancer | |
| Xu et al. | Highly emissive dye-sensitized upconversion nanostructure for dual-photosensitizer photodynamic therapy and bioimaging | |
| Lee et al. | Near-infrared light-triggered photodynamic therapy and apoptosis using upconversion nanoparticles with dual photosensitizers | |
| Hsu et al. | Lanthanide-doped core–shell–shell nanocomposite for dual photodynamic therapy and luminescence imaging by a single X-ray excitation source | |
| Liang et al. | Facile assembly of functional upconversion nanoparticles for targeted cancer imaging and photodynamic therapy | |
| Dou et al. | Effective near-infrared photodynamic therapy assisted by upconversion nanoparticles conjugated with photosensitizers | |
| Liu et al. | Covalently assembled NIR nanoplatform for simultaneous fluorescence imaging and photodynamic therapy of cancer cells | |
| Du et al. | Photodynamic graphene quantum dot: reduction condition regulated photoactivity and size dependent efficacy | |
| Zeng et al. | Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for in vivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers | |
| Zhao et al. | Multifunctional core–shell upconverting nanoparticles for imaging and photodynamic therapy of liver cancer cells | |
| Park et al. | Theranostic probe based on lanthanide‐doped nanoparticles for simultaneous in vivo dual‐modal imaging and photodynamic therapy | |
| Zhang et al. | Multimodal upconversion nanoplatform with a mitochondria-targeted property for improved photodynamic therapy of cancer cells | |
| Dong et al. | Chemical modulation of glucose metabolism with a fluorinated CaCO3 nanoregulator can potentiate radiotherapy by programming antitumor immunity | |
| Kang et al. | Tetramodal imaging and synergistic cancer radio-chemotherapy enabled by multiple component-encapsulated zeolitic imidazolate frameworks | |
| Shanmugam et al. | Multifunctional CuO/Cu2O truncated nanocubes as trimodal image-guided near-infrared-III photothermal agents to combat multi-drug-resistant lung carcinoma | |
| Song et al. | Upconversion system with quantum dots as sensitizer: improved photoluminescence and PDT efficiency | |
| Zhan et al. | Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy | |
| Zhang et al. | Low-dose x-ray excited photodynamic therapy based on naluf4: Tb 3+–rose bengal nanocomposite | |
| Sun et al. | Amphiphilic silane modified multifunctional nanoparticles for magnetically targeted photodynamic therapy | |
| Qian et al. | Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy | |
| Yu et al. | Protoporphyrin IX-loaded laminarin nanoparticles for anticancer treatment, their cellular behavior, ROS detection, and animal studies | |
| Wang et al. | Dual-Site Förster Resonance Energy Transfer Route of Upconversion Nanoparticles-Based Brain-Targeted Nanotheranostic Boosts the Near-Infrared Phototherapy of Glioma |